INmune Bio, Inc. ( INMB) - Key Metrics
INMB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | -$0.24 | -$0.20 | -$0.18 |
| 2025Q2 | ? | -$1.05 | -$0.32 | -$0.35 |
| 2025Q1 | $0 | -$0.43 | -$0.30 | -$0.30 |
INMB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -2.13 |
| 2025Q2 | ? | -0.55 |
| 2025Q1 | ? | -4.51 |
INMB
Price: $1.45
52 week price:
Earnings Per Share: -1.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 49961
Market Capitalization: 36.2 million